Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:22 AM ET 8-K
M&A Deal Worthington Steel, Inc. WS

Worthington Steel M&A Deal with Klöckner & Co SE

Worthington Steel issued a status update regarding its pending Domination and Profit and Loss Transfer Agreement (DPLTA) with Klöckner & Co SE ahead of an extraordinary general meeting. The company stated that if the DPLTA vote does not achieve the required 75% majority, it will not pursue another vote for at least one year.

Counterparty
Klöckner & Co SE
7:06 AM ET 8-K
Clinical Trial Data Roivant Sciences Ltd. ROIV

Roivant Sciences Clinical Trial Data

Roivant and its subsidiary Priovant Therapeutics announced positive results from the Phase 3 CLARITY program evaluating brepocitinib in non-infectious uveitis (NIU). The drug met its primary and all key secondary endpoints in two identical trials, demonstrating a median time to treatment failure of over 48 weeks compared to 12 weeks for placebo, and the company plans to file a supplemental New Drug Application (sNDA) in the first half of 2027.

7:02 AM ET 8-K
Clinical Trial Data Genprex, Inc. GNPX

Genprex Clinical Trial Data

Genprex highlighted peer-reviewed preclinical research published in Mechanisms of Ageing and Development regarding the TUSC2 gene, which is the therapeutic component of its REQORSA oncology program. The study found that TUSC2 deficiency in mice leads to mitochondrial dysfunction and protein homeostasis collapse in the brain, with human datasets showing TUSC2 expression also declines with age and Alzheimer's disease. While exploratory, the findings suggest TUSC2 plays a foundational role in brain health beyond its established role in cancer treatment.

Counterparty
Meharry Medical College
7:00 AM ET 8-K
Nasdaq/NYSE Compliance Notice Vivos Therapeutics, Inc. VVOS

Vivos Therapeutics Nasdaq/NYSE Compliance Notice

Vivos Therapeutics received a letter from Nasdaq confirming that the company has regained compliance with the minimum stockholders' equity requirement of $2.5 million under Listing Rule 5550(b)(1). The compliance was achieved following a transaction involving the issuance of Series C Convertible Preferred Stock, which is expected to increase stockholders' equity by more than $10 million. The company must continue to evidence compliance in its next periodic report to avoid potential delisting.

Counterparty
The Nasdaq Stock Market LLC
6:46 AM ET 8-K
M&A Deal Apex Tech Acquisition Inc. TRAD

Apex Tech Acquisition Signs $3.5B M&A Deal with Korai Flix, Inc.

APEX Tech Acquisition Inc. (a SPAC) has entered into a definitive merger agreement to acquire Korai Flix, Inc., an AI-powered interactive online entertainment platform, in a deal valuing Korai at $3.5 billion on a pre-money equity basis. Upon closing, the combined entity will be renamed Krflix Group, Inc. and is expected to list on the NYSE. The transaction is projected to close in the first quarter of 2027, subject to shareholder and regulatory approvals.

Value
$3.5B
Counterparty
Korai Flix, Inc.
6:46 AM ET 8-K
M&A Deal Nova Minerals Corp NVA

Nova Minerals Signs $3.5B M&A Deal with Korai Flix Inc.

APEX Tech Acquisition Inc. (NYSE: TRAD) has entered into a definitive merger agreement to acquire Korai Flix Inc., an AI-powered interactive online entertainment platform, in a deal valuing Korai at $3.5 billion on a pre-money equity basis. Upon closing, expected in Q1 2027, the combined company will be renamed Krflix Group Inc. and is expected to list on the NYSE.

Value
$3.5B
Counterparty
Korai Flix Inc.
6:05 AM ET 8-K
M&A Deal Silicon Valley Acquisition Corp. SVAQ

Silicon Valley Acquisition Signs $5M M&A Deal with EigenQ, Inc.

Silicon Valley Acquisition Corp. (SVAQ) provided an update on its pending merger with EigenQ, Inc., specifically announcing a subordinated unsecured note financing. SVAQ and EigenQ entered into an agreement with an investor for the issuance of up to $5 million in promissory notes and warrants to support the transaction. This financing is part of the broader capital structure required to complete the previously announced business combination.

Value
$5M
Counterparty
EigenQ, Inc.
6:04 AM ET 8-K
M&A Deal Nuburu, Inc. BURU

Nuburu M&A Deal with Tekne S.p.A.

Nuburu, Inc. completed the acquisition of an additional 67.1% interest in Tekne S.p.A. for a fixed purchase price of €5.2 million, bringing its total ownership to 70%. The deal includes a €20 million cash earn-out payable through 2036 based on 5% of annual revenues with a guaranteed annual minimum of €2 million. As part of the transaction, Nuburu waived approximately €29.7 million in receivables owed by Tekne as a capital contribution to recapitalize the entity.

Counterparty
Tekne S.p.A.
Term
Earn-out through 2036
6:04 AM ET 8-K/A
Capital Raise Cenntro Inc. CENN

Cenntro Capital Raise

Cenntro Inc. filed an amendment to a previous 8-K to include a legal opinion from Wendot Law Group regarding its at-the-market (ATM) equity offering program. The filing serves as a routine administrative update to support the company's existing registration statement for the sale of common stock.

6:03 AM ET 8-K
M&A Deal Olenox Industries Inc. OLOX

Olenox Industries Signs $22M M&A Deal with IPD Industries, Inc. and Wildboy Holdings, Ltd.

Olenox Industries completed the acquisition of IPD Industries and Wildboy Holdings for $22 million in a mix of common stock, Series F preferred stock, and cash. The deal adds natural gas processing assets in British Columbia and a 100 MW power-development platform in Texas to support the company's gas-to-power-to-compute strategy for AI and data centers.

Value
$22M
Counterparty
IPD Industries, Inc. and Wildboy Holdings, Ltd.

“Power is becoming one of the defining constraints on the growth of artificial intelligence and digital infrastructure. With these acquisitions, we are building a platform that starts with the energy itself. Wildboy gives us control of natural gas resources, and IPD gives us a registered foundation for developing power generation in West Texas. Together, they position us to capture more value across the chain -- from gas to electricity to computing.”

Michael McLaren, Chairman and Chief Executive Officer of Olenox
6:02 AM ET 8-K
M&A Deal Grown Rogue International Inc. GRUSF

Grown Rogue International Signs $743K M&A Deal with ABCO Garden State, LLC

Grown Rogue International Inc. has exercised its second option to acquire an additional 26% ownership interest in its New Jersey subsidiary, ABCO Garden State, LLC, for approximately $0.743 million. This transaction increases the company's total ownership stake to 70% and grants it majority control of ABCO's board of directors following approval from the New Jersey Cannabis Regulatory Commission.

Value
$743K
Counterparty
ABCO Garden State, LLC

“We're very pleased with how New Jersey is performing, and this step is largely a formality as we continue to focus on completing our canopy expansion and growing the business.”

Obie Strickler, CEO of Grown Rogue

“We remain on schedule to have construction of Phase II substantially complete by the end of 2026, bringing total New Jersey flowering canopy to approximately 16,000 square feet, with the additional capacity ramping into 2027.”

Obie Strickler, CEO of Grown Rogue
6:30 PM ET
Earnings Call Neptune Insurance Holdings Inc. NP ▶ Call

Neptune Insurance Holdings Earnings Call: Key Takeaways

Neptune Insurance delivered record Q3 results with 34% revenue growth and significant margin expansion, driven by AI-powered agent productivity and a capital-light model despite headwinds in housing and weather.

Call
Oct 20, 2026, 5:00 PM ET
5:31 PM ET 8-K/A
M&A Deal Aspire-Lakewood Holdings, Inc. ASBP

Aspire-Lakewood Holdings Signs $30M M&A Deal with Dura Driver Control Systems

Aspire-Lakewood Holdings completed the acquisition of Dura Driver Control Systems (DCS) for a purchase price of $30 million. In connection with the closing, the company entered into a five-year management services agreement with Lakewood Capital, LLC, which includes a $0.5 million closing fee and a 15% equity stake in the acquired entity for the service provider.

Value
$30M
Counterparty
Dura Driver Control Systems
Term
5 years
5:30 PM ET 8-K
M&A Deal Dream Finders Homes, Inc. DFH

Dream Finders Homes Signs $878M M&A Deal with Beazer Homes USA, Inc.

Dream Finders Homes completed its acquisition of Beazer Homes USA, Inc. for approximately $878.4 million in cash, creating the sixth-largest U.S. homebuilder. Beazer shareholders received $33.50 per share, and the company's stock has been delisted from the NYSE. The transaction expands Dream Finders' footprint into 26 of the top 50 MSAs and is expected to generate over $100 million in annual cost synergies.

Value
$878M
Counterparty
Beazer Homes USA, Inc.

“Today, Beazer’s teams officially join ours, and the real work begins. We are closing this transaction in a challenging housing environment, and we are clear-eyed about that. But we believe this acquisition is transformative for Dream Finders. It makes us the nation’s sixth-largest homebuilder and brings us into new markets where Beazer was already proficient.”

Patrick Zalupski, Founder, CEO, and Co-Chairman of Dream Finders

“With the acquisition completed, the Board’s focus now turns to disciplined execution. This combination is built to perform throughout the housing market cycle. We continue to expect over $100 million of annual run-rate cost synergies and double-digit percentage EPS accretion in year one, while expanding our financial services platform and preserving the asset-light model that underpins our returns.”

Rick Beckwitt, Co-Chairman of Dream Finders
5:29 PM ET 8-K
Nasdaq/NYSE Compliance Notice Sports Entertainment Gaming Global Corp SEGG

Sports Entertainment Gaming Global Nasdaq/NYSE Compliance Notice

Sports Entertainment Gaming Global Corp received a Nasdaq Staff Determination letter on October 14, 2026, notifying the company of a delisting threat due to its failure to file its Q2 2026 Form 10-Q. The company has requested a hearing before the Nasdaq Hearings Panel to stay the suspension of its common stock and warrants and present a plan to regain compliance.

Counterparty
Nasdaq
5:22 PM ET 8-K
M&A Deal DoubleVerify Holdings, Inc. DV

DoubleVerify Holdings M&A Deal with Neptune BidCo US Inc.

DoubleVerify Holdings provided a status update on its pending acquisition by Neptune BidCo US Inc. (a parent company of Nielsen). The filing discloses that the merger received regulatory clearance from the German Federal Cartel Office on October 5, 2026, and supplements the company's definitive proxy statement with updated antitrust filing timelines for other jurisdictions.

Counterparty
Neptune BidCo US Inc.
5:10 PM ET 8-K
M&A Deal ESG Inc. ESGH

ESG M&A Deal with BevPoint Capital LP

ESG Inc. entered into a Control Share Purchase and Transfer Agreement where DCG China Limited will sell 9,641,110 shares (approximately 61.8% of the company) to BevPoint Capital LP for $250,000. The deal represents a change of control that will result in the resignation of incumbent officers and directors and the appointment of BevPoint-designated successors upon closing. The agreement also contemplates a future business combination involving BevPoint's operating business.

Counterparty
BevPoint Capital LP
5:05 PM ET 8-K
Capital Raise Surrozen, Inc. SRZN

Surrozen Capital Raise of $95.1M

Surrozen completed the second and final tranche of a private placement, raising approximately $95.1 million in gross proceeds. The closing was triggered by the achievement of a milestone involving FDA clearance of the IND application for SZN-8141. The funding is expected to provide a cash runway into 2029 to advance the company's ophthalmology pipeline through clinical milestones.

Value
$95.1M

“The completion of this financing marks an important milestone for Surrozen, significantly strengthening our balance sheet and providing the resources to advance our ophthalmology pipeline through multiple important clinical milestones.”

Craig Parker, President and Chief Executive Officer

“With expected cash runway into 2029, we are well positioned to advance SZN-8141 into the DUET Phase 1b/2a study and initiate clinical development of SZN-8143, while maintaining a disciplined approach to capital allocation.”

Craig Parker, President and Chief Executive Officer
5:04 PM ET 8-K
M&A Deal CBRE Group, Inc. CBRE

CBRE Group Signs $610M M&A Deal with Onnec Group Limited

CBRE Group, Inc. has entered into a definitive agreement to acquire Onnec Group Limited, a London-based provider of data center infrastructure services, for an initial cash price of £460 million (approximately $610 million). The deal includes a multi-year earnout of up to £300 million ($400 million) and is intended to expand CBRE's global critical infrastructure capabilities across Europe and Asia Pacific.

Value
$610M
Counterparty
Onnec Group Limited
5:01 PM ET 8-K
Capital Raise Treasure Global Inc TGL

Treasure Global Capital Raise of $1.2M

Treasure Global Inc entered into subscription agreements with three investors, including its Acting CEO and CFO, to raise an aggregate of $1.2 million through the sale of common stock. The investment will be made in two equal tranches of $200,000 per investor, with the share price set at the greater of $0.45 or the closing price prior to completion. The offerings are being conducted under Regulation S and involve restricted securities subject to a six-month distribution compliance period.

Value
$1.2M
Counterparty
Chan Meng Chun, Pusparajan a/l Vadiveloo and Teo Chong Chan
4:46 PM ET 8-K
Nasdaq/NYSE Compliance Notice SHF Holdings, Inc. SHFS

SHF Holdings Nasdaq/NYSE Compliance Notice

SHF Holdings received a formal 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company met all other listing standards and has notified Nasdaq of its intent to cure the deficiency, potentially through a reverse stock split if necessary.

Counterparty
The Nasdaq Stock Market LLC
Term
180 days
4:38 PM ET 8-K
Capital Raise Indaptus Therapeutics, Inc. INDP

Indaptus Therapeutics Capital Raise of $24M

Indaptus Therapeutics completed a private placement of 20,338,974 shares of common stock for aggregate gross proceeds of approximately $24.0 million. The closing follows a previously announced stock purchase agreement dated September 8, 2026, and a subsequent extension of the outside closing date to October 16, 2026.

Value
$24M
4:31 PM ET 8-K
Capital Raise Conexeu Sciences Inc. CNXU

Conexeu Sciences Capital Raise of $4M

Conexeu Sciences Inc. closed a private placement of 1,333,333 units at $3.00 per unit for gross proceeds of approximately $4.0 million. Each unit consists of one share of common stock and one warrant to purchase an additional share at $3.00. The company intends to use the proceeds for working capital and general corporate purposes.

Value
$4M
4:31 PM ET 8-K
M&A Deal Lifecore Biomedical, Inc. \De\ LFCR

Lifecore Biomedical, Inc. \De\ M&A Deal with Lifecore Inc.

Lifecore Biomedical established November 4, 2026, as the record date for a special meeting of stockholders to vote on its previously announced merger agreement with Lifecore Inc. and Hazel Merger Sub, Inc. The company will file a proxy statement to solicit shareholder approval for the adoption of the merger agreement.

Counterparty
Lifecore Inc.
4:15 PM ET 8-K
Capital Raise Pure Bioscience, Inc. PURE

Pure Bioscience Capital Raise of $555K

PURE Bioscience completed a private placement financing raising $555,000 through the issuance of 10,183,486 shares of common stock. The investment was made by board member Tom Y. Lee and his affiliates at a price of $0.0545 per share, with proceeds intended for research, development, and general working capital.

Value
$555K
Counterparty
Tom Y. Lee
4:12 PM ET 8-K
Capital Raise Blue Owl Real Estate Net Lease Trust ORENT

Blue Owl Real Estate Net Lease Trust Capital Raise of $31M

Blue Owl Real Estate Net Lease Trust sold 2,883,572 Class I common shares to feeder vehicles for gross proceeds of approximately $31.0 million. The shares were priced based on the September 30, 2026 net asset value (NAV) of $10.7668 per Class I share. The company also reported a total portfolio fair value of approximately $15.6 billion across 4,097 properties.

Value
$31M
4:06 PM ET 8-K
Divestiture Bluerock Homes Trust, Inc. BHM

Bluerock Homes Trust Divestiture for $6.6M

Bluerock Homes Trust completed the disposition of 31 single-family residential units within its ILE portfolio between January 1 and October 14, 2026. The units were sold to unaffiliated third parties for an aggregate sales price of approximately $6.6 million, resulting in net proceeds of approximately $2.0 million after debt paydown.

Value
$6.6M
4:06 PM ET 8-K
Capital Raise First Tracks Biotherapeutics, Inc. TRAX

First Tracks Biotherapeutics Capital Raise

First Tracks Biotherapeutics, Inc. closed a private placement of 6,106,870 shares of common stock on October 19, 2026. In connection with the closing, the company entered into a registration rights agreement requiring it to file a resale registration statement for the investors within 30 days.

4:06 PM ET 8-K
M&A Deal Marwynn Holdings, Inc. MWYN

Marwynn Holdings M&A Deal with Zhituo Software Co., Limited

Marwynn Holdings acquired the proprietary Phase 1 core platform of the Marwynn Group Operating Platform from Zhituo Software Co., Limited. As consideration, the company agreed to issue 4,000,000 shares of common stock, which will serve as the permanent core architecture for managing the company and its subsidiaries. The agreement includes the transfer of all worldwide intellectual property rights, source code, and technical documentation.

Counterparty
Zhituo Software Co., Limited
4:00 PM ET 8-K
Capital Raise North Haven Net REIT

North Haven Net REIT Capital Raise of $9.25M

North Haven Net REIT sold an aggregate of 442,000 shares across multiple classes (Class I, F-I, E, and L-I) for total consideration of approximately $9.25 million. The shares were sold to a feeder vehicle and other investors based on the company's net asset value per share as of September 30, 2026.

Value
$9.25M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.